The Centers for Disease Control and Prevention intends to award a sole source, firm fixed price contract, in accordance with FAR Part 13.106-1, using simplified acquisition procedures, to the Texas A &M, College Station, TX, 77843. Texas A&M will process and analyze urine samples to measure aflatoxin ML and urine creatinine and provide assistance is disseminating study findings in Kenya.

Texas A&M appears to be the only organization that can provide this service. The organization is the only group that has assessed the safety, palatability and efficacy of ACS100 clay limit of the absorption of fungal toxins from contaminated food in Africa and has supervised five human intervention trials of ACS100 clay in North America and Africa; and has performed mitigation of dietary and environmental risk factors for disease using absorbent clays in vulnerable populations of North America and Africa. Texas A&M is the only provider of clay produced that has been extensively tested in Africa to reduce aflatoxin exposure without effecting micronutrient levels. Texas A&M is the only one responsible source and no other services will satisfy the agency requirements; in accordance with FAR 6.302-1, this is sole source requirement. This advertisement ends in 5 days accordance with FAR 5.203 (A) (1). No Request for Quotes (RFQ) will be issued based upon this Notice of Intent. Any interested companies are welcome to submit their credentials and ability to provide the services, via e-mail, [email protected] . Include reference number (2014-72181). Send responses by Wednesday July 16, 2014.